Li Dean Y
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Li Dean Y. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| RXRX | Award / Grant | 1,961 | — | — | Oct 1, 2025 | |
| RXRX | Award / Grant | 1,949 | — | — | Jul 1, 2025 | |
| RXRX | Award / Grant | 22,016 | — | — | Jun 18, 2025 | |
| RXRX | Award / Grant | 2,268 | — | — | Apr 1, 2025 | |
| MRK | Executive VP & President, MRL | Award / Grant | 32,621 | $97.94 | $3,194,901 | Jan 27, 2025 |
| RXRX | Award / Grant | 1,647 | — | — | Jan 2, 2025 | |
| RXRX | Award / Grant | 1,925 | — | — | Oct 1, 2024 | |
| RXRX | Award / Grant | 1,592 | — | — | Jul 1, 2024 | |
| RXRX | Award / Grant | 13,097 | — | — | Jun 3, 2024 | |
| RXRX | Award / Grant | 1,267 | — | — | Apr 1, 2024 | |
| MRK | Executive VP & President, MRL | Sale | 14,702 | $125.50 | $1,845,101 | Feb 9, 2024 |
| MRK | Executive VP & President, MRL | Award / Grant | 25,760 | $119.43 | $3,076,517 | Jan 22, 2024 |
| RXRX | Sale | 28,038 | $13.65 | $382,719 | Jan 9, 2024 | |
| RXRX | Award / Grant | 1,203 | — | — | Jan 2, 2024 | |
| RXRX | Gift | 627,705 | — | — | Oct 2, 2023 | |
| RXRX | Award / Grant | 1,609 | — | — | Jul 3, 2023 | |
| RXRX | Award / Grant | 12,612 | — | — | Jun 16, 2023 | |
| MRK | Executive VP & President, MRL | Option Exercise | 1,062 | $115.47 | $122,629 | May 1, 2023 |
| RXRX | Award / Grant | 1,724 | — | — | Apr 3, 2023 | |
| MRK | Executive VP & President, MRL | Award / Grant | 3,275 | $109.88 | $359,857 | Jan 23, 2023 |
| RXRX | Award / Grant | 1,573 | — | — | Jan 3, 2023 | |
| RXRX | Award / Grant | 1,092 | — | — | Oct 3, 2022 | |
| RXRX | Award / Grant | 1,409 | — | — | Jul 1, 2022 | |
| RXRX | Award / Grant | 18,145 | — | — | Jun 14, 2022 | |
| MRK | Executive VP & President, MRL | Option Exercise | 773 | $87.65 | $67,753 | May 3, 2022 |
| MRK | Executive VP & President, MRL | Option Exercise | 1,061 | $88.69 | $94,100 | May 1, 2022 |
| RXRX | Award / Grant | 1,544 | — | — | Apr 1, 2022 | |
| MRK | Executive VP & President, MRL | Award / Grant | 3,023 | $73.51 | $222,221 | Feb 24, 2022 |
| RXRX | Award / Grant | 659 | — | — | Jan 3, 2022 | |
| RXRX | Sale | 14,900 | $20.44 | $304,556 | Dec 7, 2021 | |
| RXRX | Sale | 5,626 | $20.04 | $112,745 | Nov 19, 2021 | |
| RXRX | Sale | 13,474 | $20.20 | $272,175 | Nov 17, 2021 | |
| RXRX | Award / Grant | 543 | — | — | Oct 1, 2021 | |
| RXRX | Award / Grant | 330 | — | — | Jul 1, 2021 | |
| MRK | Executive VP & President, MRL | Option Exercise | 694 | $75.98 | $52,730 | May 4, 2021 |
| MRK | Executive VP & President, MRL | Option Exercise | 750 | $74.50 | $55,875 | May 3, 2021 |
| RXRX | C | 55,383 | — | — | Apr 20, 2021 | |
| RXRX | Award / Grant | 13,889 | — | — | Apr 16, 2021 | |
| MRK | Executive VP & President, MRL | Award / Grant | 3,485 | $72.62 | $253,081 | Feb 26, 2021 |